v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current assets    
Cash and cash equivalents $ 11,210 $ 4,235
Accounts receivable 54 30
Research and development tax credit receivable 452 1,121
Prepaid expenses and other current assets 1,018 1,056
Total current assets 12,734 6,442
Property, plant and equipment, net 503 602
Right-of-use assets, net 337 475
Other assets, non-current 6 6
Total assets 13,580 7,525
Current liabilities    
Accounts payable and accrued expenses 1,453 931
Lease liabilities, current 228 206
Income tax payable   22
Other current liabilities 147 244
Total current liabilities 1,828 1,403
Lease liabilities, non-current 75 239
Warrant liability 1,376  
Total liabilities 3,279 1,642
Commitments and contingencies (Note 6)
Stockholders' equity:    
Preferred stock, par value $0.0001 per share, 10,000,000 shares authorized, 13,879 and zero shares issued and outstanding, at September 30, 2023 and December 31, 2022, respectively
Common stock, par value $0.0001 per share, 300,000,000 shares authorized, 876,278 and 771,054 shares issued and outstanding, at September 30, 2023 and December 31, 2022, respectively *
Additional paid-in capital 104,571 92,933
Accumulated other comprehensive loss (606) (483)
Accumulated deficit (93,664) (86,567)
Total stockholders' equity 10,301 5,883
Total liabilities and stockholders' equity $ 13,580 $ 7,525

Source